| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| INTLI - Finanziamenti internazionali |
Unveiling the impact of ASGR1 deficiency on the immunoinflammatory signature during atherogenesis (ASGR1 )
|
|
Closed | 2018 |
| INTLI - Finanziamenti internazionali |
Bioinformatics and cell reprogramming to develop an in vitro platform to discover new drugs for progressive multiple sclerosis (BRAVEinMS)
|
|
Closed | 2018 |
| INTLI - Finanziamenti internazionali |
Bioinformatics and cell reprogramming to develop an in vitro platform to discover new drugs for progressive multiple sclerosis (BRAVEinMS)
|
|
Closed | 2018 |
| INTLI - Finanziamenti internazionali |
PCSK9 and cardiac function: bridging cellular lipid metabolism to mitochondrial function and heart failure (PCSK9)
|
|
Closed | 2018 |
| INTLI - Finanziamenti internazionali |
Linking PCSK9 to beta-cell physiology and glucose metabolism
|
|
Closed | 2018 |
| INTLI - Finanziamenti internazionali |
Investigation on the possible role of micrornas in the regulation of chemical allergen potency
|
|
Closed | 2018 |
| MAE_GR - Bandi Affari Esteri e Cooperazione Internazionale - PROGETTI DI GRANDE RILEVANZA |
New generation drugs against Plasmodium falciparum trasmission for malaria eradication (I ANNO)
|
|
Closed | 2018 |
| MIS - Bandi Ministero Salute |
Dysbindin-antipsychotics psychophamarcogenetics: a mouse-human translational study towards personalized healthcare in bipolar disorders
|
|
Closed | 2018 |
| MIS - Bandi Ministero Salute |
Combined Next-generation sequencing and in vivo approach to uncover the complex genetic basis of GnRH neuron deficiency
|
|
Closed | 2018 |
| PON PNR 2015-2020 |
Medicina personalizzata per strategie innovative in malattie neuro-psichiatriche e vascolari (PerMedNet)
|
|
Closed | 2018 |
